CurveBeam AI combines market leading point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI) expertise to deliver solutions across orthopedics and bone health (fragility fracture prevention). CurveBeam AI’s global operations headquarters for product development, Regulatory, manufacturing, and operations including sales, marketing, and customer care will remain in Hatfield, Pennsylvania. CurveBeam AI’s corporate office in Melbourne will cover AI research & development, corporate finance, and IP functions.
CurveBeam AI listed on the ASX in August 2023.